TetraPhase Pharmaceuticals Announces Participation in Session on New Treatments for Multidrug-Resistant Gram-Negative Bacteria at 2010 Biotechnology Industry Organization (BIO) International Convention

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals Inc., a biopharmaceutical company developing novel antibiotics based on proprietary synthetic chemistry technology, today announced that it will be participating in a session on drug discovery and development of novel treatments for drug-resistant infections, taking place at the 2010 BIO International Convention in Chicago.

Back to news